SCHEMBL8971604

SCHEMBL8971604

CCOc1ccc(-c2ccc(-c3ccc(OC(F)(F)C4CCCCC4)cc3F)cc2)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.38
APP P05067 2/20 0.36
PTPRC P08575 1/20 0.34
CYP2C9 P11712 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
ESR1 P03372 1/20 0.34
CYP3A4 P08684 1/20 0.33
TACR1 P25103 1/20 0.33
MCHR1 Q99705 1/20 0.33
NAAA Q02083 1/20 0.32
HCRTR1 O43613 3/20 0.32
HCRTR2 O43614 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13000306 0.80 GRM2 (0.40) GRM2ALDH1A1LMNAALOX5APFEN1
SCHEMBL8971890 0.80 GRM2 (0.34) GRM2APPCYP2C9
SCHEMBL10164877 0.79 GRM2 (0.36) GRM2APPCYP2C9ALOX5APFEN1
SCHEMBL8971058 0.78 HPGD (0.44) APPCYP2C9ALDH1A1HPGDMAPT
SCHEMBL9019618 0.78 CYP3A4 (0.46) APPPTPRCCYP2C9ALDH1A1LMNA
SCHEMBL8972160 0.77 NAAA (0.36) PTPRCALDH1A1NAAAHCRTR1HCRTR2
SCHEMBL8972234 0.77 CYP3A4 (0.40) APPPTPRCCYP2C9ALDH1A1LMNA
SCHEMBL8971563 0.77 GRIN1 (0.35) PTPRCFFAR4
SCHEMBL12113647 0.76 NAAA (0.35) PTPRCALDH1A1NAAAHCRTR1HCRTR2
SCHEMBL17365977 0.76 ALOX5AP (0.37) GRM2APPCYP2C9LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE KIF23, HCN3, FZD7 GRM2 3313/4885APP 2488/4885PTPRC 2204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.